Patent · US Active

3-aza-bicyclo[3.3.0]octane compounds

US8106215B2 · kind B2 · utility

13Cited by

1References

15Claims

0Family size

Assignee

Actelion Pharmaceuticals Ltd. · CH

Inventors

Hamed Aissaoui · Allschwil, CH
Christoph Boss · Allschwil, CH
Markus Gude · Allschwil, CH
Ralf Koberstein · Bad Kötzting, DE
Thierry Sifferlen · Allschwil, CH

Key dates

Filing date	Jul 2, 2008
Grant date	Jan 31, 2012
Priority date	—
Expiry date	Jul 2, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to 3-aza-bicyclo[3.3.0]octane derivatives of the formula (I) wherein R1, R2, R3, and A are as described in the description and their use as orexin receptor antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.